As we know, epithelial–mesenchymal transition (EMT) is a key event in tumor invasion (Dosemeci et al. 2007) and TGF-β1 is an important inducer of EMT in cancer progression (McClatchy et al. 2007). The gene discussed is TGFB1; the disease is cancer.